Business Wire

MA-BRIGHTCOVE

15.4.2024 15:01:27 CEST | Business Wire | Press release

Share
Brightcove Introduces Smart TV SDKs for Roku, Samsung, and LG Devices, Empowering Media Companies to Reach New Audiences

Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of its new player platforms for Roku, Samsung and LG Smart TVs. The launch of the new Software Development Kits (SDKs) has unlocked advanced features within Brightcove’s industry-leading player framework, including content protection, monetization, and analytics reporting capabilities. Designed to reduce the cost and speed of high-quality app development, media companies can more effectively target the Smart TV platforms fueling media growth while delivering a consistent, engaging premium viewer experience.

“Brightcove is committed to helping media companies deliver engaging and world-class reliable streaming experiences while reducing the costs traditionally associated with launching and running an OTT service," said Scott Levine, Chief Product Officer at Brightcove. “Our comprehensive platform enables media companies to benefit from out-of-the-box functionality and deliver premium app experiences with features previously only available in bespoke custom app development - at a fraction of the cost. "

Brightcove developed the SDKs with advertising needs in mind, supporting client-side and server-side ad insertion (CSAI, SSAI) and integrating them with digital advertising partners. Brightcove’s Roku SDK also complies with the Roku Advertising Framework (RAF), facilitating the certification process for customers. Brightcove’s Smart TV SDKs improve media handling and offer sophisticated content security capabilities, including multi-format DRM support, playback rights restrictions, and HDCP Fallback, seamlessly enabling secure delivery of premium content across all platforms.

Brightcove’s industry-leading Insights solutions also come pre-integrated. These insights, driven by the usage of the Smart TV SDKs, allow media companies to optimize ad breaks, improve player performance, identify content performance trends, pinpoint the cause of streaming quality issues, and measure impacts on viewer engagement, all to inform and enrich content, monetization and distribution strategies. The Smart TV SDKs automatically collect and report the session details impacting viewer satisfaction at scale, providing a clearer picture of overall streaming service performance and ensuring better viewer experiences.

In concert with the launch of the Smart TV SDKs, Brightcove has brought together a collection of the best video app developers to deliver options for media companies looking to meet viewers wherever they are. Partners include:

  • Accedo – a global video solutions provider powering some of the world’s most impactful and engaging video-centric experiences. Accedo offers quick launch and simplified management with their Accedo One platform, or fully customizable solutions for companies looking to truly differentiate their video app experiences.
  • Applicaster – helps content owners, OTT providers, and publishers connect with their audiences and drive business performance. The company’s Zapp platform is the industry’s most innovative no/low-code app management platform designed to give businesses the control, agility, and data they need to grow.
  • Appsfactory – a paramount European digital agency boasting an illustrious 14-year history of crafting and deploying successful digital products and solutions.
  • Arx.net/SoEasyTV – an established OTT applications provider that has developed and maintains multiple tailor-made OTT applications for large Pay TV Service Providers that support all platforms and operate with different video backend platforms. SoEasyTV OTT applications are a white-label solution that provides powerful functionalities, flexibility and a common user experience across all connected devices.
  • Enveu – an end-to-end OTT technology solutions provider to build, launch, manage and grow a video streaming business across 12+ platforms, dedicated to helping media publishers and content creators.
  • Pulselive – digital partner to some of the biggest names in sports, creating and powering digital experiences that engage millions of sports fans every day via digital products, including websites, mobile applications and emerging technologies.
  • Spyrosoft BSG – Spyrosoft BSG (formerly known as Better Software Group) is revolutionizing digital media consumption by offering modern solutions tailored to the needs of content distributors such as broadcasters, media agencies, telecommunications companies and sports organizations.
  • Robosoft Technologies – a proven digital transformation partner with a track record of crafting 10+ leading OTT streaming platforms enjoyed by millions across the globe.
  • TV2Z – a global supplier of premium cloud-based OTT services that builds and launches streaming solutions across multiple devices and operators.

The Smart TV SDKs add to Brightcove’s already leading players (which currently service ​​Web, Android, Android TV, Fire TV, iOS, iPad OS, and tvOS platforms) to propel media companies to be able to meet their audiences on any device.

For more information, visit Brightcove.com.

About Brightcove Inc.

Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415787309/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye